Previous studies on the association between blood pressure (BP) variability in acute ischemic stroke and functional outcomes have yielded conflicting results. We aimed to investigate the predictive significance of day-to-day BP variability during the 7 days following stroke onset for functional outcomes at 12 months.
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Blood pressure (BP) elevation in acute ischemic stroke is a common phenomenon, 1 and it is presumed to play a double-edged role in the post-stroke pathophysiological cascade. Elevated BP may be beneficial to compensate for cerebral perfusion of the infarct and surrounding penumbra; however, it may also be potentially detrimental with regard to exacerbating brain edema and causing intracranial hemorrhage. Post hoc analyses and most observational studies have indicated significant associations between BP elevation and poor outcomes. [2] [3] [4] [5] Nevertheless, several randomized controlled trials designed to test the rationale of BP reduction strategies in acute ischemic stroke have failed to verify its clinical benefit. [6] [7] [8] The elucidation of strategies to optimize BP management in acute ischemic stroke remains challenging.
Within the week after stroke onset, the elevated BP level spontaneously declines, 9 and this trend in BP fluctuation or variability ranges across the transitional period from the acute phase to the ensuing subacute phase. BP variability in the acute phase has been associated with poor functional outcomes at 3 months; 2,10-12 however, there are conflicting results. 10, 13 In 2 large prospective studies, BP variability in the subacute phase was demonstrated to be an independent predictor of poor functional outcomes at 3 months. 14, 15 The empirical temporal partition between the acute and subacute phases has opened the lines of query in terms of severe stroke with unstable, progressive conditions; however, it may be reasonable for mild stroke. The significance of BP variability across the entire transitional period may be informative for both mild and severe stroke; however, the relevant data are not currently available. We hypothesized that BP variability over the transitional timeline could be equally indicative for outcome prediction, regardless of the stroke severity (mild or severe). A recent study reported that visitto-visit systolic BP (SBP) variability predicted long-term cerebral microbleeds and white matter lesions in patients following lacunar infarct. 16 In this study, we aimed to investigate whether BP variability in the ensuing week after stroke Predictive Significance of Day-to-Day Blood Pressure Variability in Acute Ischemic Stroke for 12-Month Functional Outcomes onset was associated with long-term post-stroke prognosis and to identify the specific BP variability indices that could reliably predict post-stroke functional outcomes.
METHODS

Patients
We prospectively registered patients who were admitted to Dongguan People' s Hospital, Guangdong Province, China with acute ischemic stroke explicitly within 24 hours after onset between 1 January 2014 and 31 May 2015. A cranial computerized tomography scan was conducted at admission to exclude primary intracranial hemorrhage, with the exception of secondary hemorrhage transformations during hospitalization. Magnetic resonance imaging was routinely performed the day after onset to clarify the cause and infarct location of the stroke. Patients who were admitted for recurrent ischemic stroke with noticeable premorbid disability (modified Rankin scale, mRS ≥ 2) without detailed BP monitoring data, who refused to undertake continuous BP monitoring, or who received intravenous vasoactive drugs or volumetric supplements were excluded from the study. Additional exclusion criteria included: (i) isolated sensory symptoms, isolated visual changes, isolated dizziness, or vertigo without explicit magnetic resonance imaging-diffusion weighted image lesions; and (ii) coexisting severe systemic diseases, such as acute coronary syndrome, malignant tumors, renal failure that required plasma dialysis therapy, cirrhosis, or rheumatic disease, which would influence the independent function of the patient.
Previous medical histories of cardiovascular risk factors (hypertension, smoking, cardiovascular diseases, diabetes mellitus, dyslipidemia, and renal diseases) were recorded. The stroke severity at admission was assessed using the National Institutes of Health Stroke Scale (NIHSS). The radiological features of infarction and the results of the routine lab investigations were obtained through the patient's electronic medical records. This investigation was an observational study, and the attending physicians made good practice for the best interest of the individual patient based on the acute stroke management guidelines. 17, 18 The local hospital's ethics committee approved this study, and written informed consent was obtained from all of the patients or their relatives.
BP measurement and BP variability
After admission, the patients were immediately admitted to the stroke unit, where centralized BP monitoring was performed for at least 24 hours (Mindray-Hypervisor VI, Mindray Bio-Medical Electronics, Shenzhen, China). The average time interval between symptom onset and the commencement of BP monitoring was 10.0 hours (quartile: 4.5-24.0 hours). The patients maintained a supine position with the head of the bed elevated 15 to 30 degrees, and the bedside monitor was mounted on the nonparalyzed arm. The BP was measured and automatically recorded every hour for at least 24 hours. A standard mercury sphygmomanometer was simultaneously used to measure the patient's BP at 7:00 am every morning as part of the routine nursing care. These BP measurements were automatically or manually entered into the patient's electronic medical record. The 24-hour BP variability parameters were derived for the SBP and diastolic BP (DBP) on the basis of initial 24 BP measurements according to previously described methods 19, 20 and included the mean, SD, coefficient of variability (CV), and average real variability. The day-to-day BP variability parameters were derived for both the SBP and DBP and included the mean, maximum-minimum (Max-Min), SD, and CV.
Outcome definition
A trained stroke nurse (J.S.Z.) assessed the functional outcomes at 12 months post-stroke over the telephone using a standardized mRS questionnaire. We applied the baseline severity-adjusted analysis to dichotomize the functional outcomes. 14 Functional independence was defined as follows: if the NIHSS score at admission was ≤7, the mRS was between 0 and 1; if the NIHSS score at admission was between 8 and 14, the mRS was between 0 and 2; and if the NIHSS score at admission was ≥15, the mRS was between 0 and 3.
Statistical analyses
The continuous variables are represented as the mean ± SD or median (quartiles), and the categorical variables are represented as percentages. The baseline characteristics between the 2 groups were compared using Student's t-tests, Mann-Whitney tests or λ 2 tests, depending on the appropriate value properties.
To investigate the influence of the baseline severity on the BP status and BP variability, the patients were divided into 4 groups according to the quartiles of the baseline NIHSS, and all of the BP variability parameters were subsequently compared among the groups. The 24-hour BP and day-to-day BP variability parameters were also compared to the 24-month functional outcomes.
Multivariate logistic regression models were constructed to examine the association between BP variability and the 12-month functional outcomes. The BP and BP variability parameters in terms of the day-to-day measurements were included as categorized variables based on the quartiles. Multivariate model 1 included the age, gender, risk factors (including hypertension, cardiovascular diseases, diabetes mellitus, dyslipidemia, renal diseases, and smoking), the time from onset to the door, the baseline NIHSS, the location of the infarction, the use of thrombolysis therapy, in-hospital infections, and the fasting serum glucose level. Model 2 included the mean BP in addition to the above factors. Values of P <0.05 were considered statistically significant in all tests. All statistical analyses were conducted using SPSS (IBM version 22.0).
RESULTS
Population characteristics
Among the 264 patients who initially met the inclusion criteria, 33 patients were discharged or died within 7 days or were transferred to other facilities because of severe complications, and 13 patients were lost to follow-up or refused to respond during the follow-up. Thus, 218 eligible patients were enrolled in this study. Overall, the mean age of the study population was 66.0 years, 68.8% were males, the median NIHSS at admission was 6 (interquartile range, 4-9), 76.1% had lesions located in the anterior cerebral circulation, and 10.6% received thrombolysis. The 46 excluded patients were older and had higher baseline NIHSS scores.
Association between the stroke severity and BP variability indices
The baseline NIHSS quartiles were applied to represent a distinctive stroke severity at admission. Modest yet statistically significant differences were identified for the 24-hour mean SBP, the 24-hour mean DBP, and the DBP-SD. Furthermore, there was a dose-response trend between the 24-hour mean SBP and the stroke severity. There was no significant difference for the day-to-day BP variability among each baseline quartile ( Table 1) .
Comparison of the baseline characteristics
In the baseline severity-adjusted outcome analysis, 107 patients (49.1%) were defined as having poor functional outcomes at 12 months after stroke. A comparison of the baseline characteristics is summarized in Table 2 . The patients with poor outcomes were more likely to be female, had a higher proportion of previous risk factors (including hypertension, diabetes mellitus, coronary heart diseases, previous stroke, or renal diseases), suffered more severe neurological deficits at admission, had a higher incidence of in-hospital infections, and had higher fasting serum glucose levels.
Comparison of the BP and BP variability indices
In the first 24 hours after admission, there was a significant difference in the 24-hour mean SBP between the patients with poor outcomes and the patients with good outcomes at 12 months (146.0 ± 20.1 vs. 137.5 ± 19.7 mm Hg, respectively, P = 0.002). No other significant differences were identified in the 24-hour BP variability parameters (Table 3) . For the first 3 days after stroke, the mean daily morning SBP of the patients with worse outcomes was significantly higher than the patients with good outcomes (148.2 ± 23.8 vs. 141.2 ± 22.0 mm Hg, respectively, P = 0.038). This difference gradually diminished within the subsequent 4 days (Figure 1 ). In addition, the day-to-day BP variability parameters were significantly different based on the 12-month Abbreviations: ARV, average real variability; CV, coefficient of variability; DBP, diastolic blood pressure; NIHSS, National Institutes of Health Stroke Scale; Q, quartiles; SBP, systolic blood pressure; Δ = maximum − minimum. Abbreviations: ARV, average real variation; CV, coefficient variation; DBP, diastolic blood pressure; SBP, systolic blood pressure; Δ = maximum − minimum. functional outcomes. Specifically, the patients with worse 12-month functional outcomes had significantly higher dayto-day SBP variability parameters (SBP SD, SBP CV, and SBP Max-Min) than the patients with good outcomes. The same finding was true for the DBP variability parameters (DBP-SD, DBP-CV, and DBP Max-Min).
Association of day-to-day BP variability and 12-month functional outcomes
The multivariable logistic regression of model 1 indicated that the day-to-day SBP-SD and SBP Max-Min were associated with the 12-month functional outcomes post-stroke. After further adjusting for the daily mean SBP in model 2, the SBP Max-Min was independently associated with poor outcomes at 12 months. No association was identified between DBP variability and the functional outcomes (Table 4) .
DISCUSSION
The objective of the current study was to investigate the predictive significance of BP variability in acute ischemic stroke for long-term functional outcomes. The main findings indicated that the day-to-day SBP variability was independently associated with an increased risk of worse outcomes over 12 months. Furthermore, there was a significant difference in the morning BP levels in the first 3 days post-stroke between the patients with good outcomes and the patients with worse outcomes; however, this difference diminished in the subsequent 4 days. The 24-hour BP and BP variability indices in the acute stage were associated with the stroke severity at admission; however, no association was identified with regard to the long-term outcomes.
Previous studies have supported our main finding. The Fukuoka stroke registry, which recruited 61.4% of minor stroke patients, demonstrated an independent association between the day-to-day BP variability in the subacute stage and poor functional outcomes at 3 months. 15 Moreover, a large observational study using a baseline severity-adjusted analysis reported similar results. 14 However, it is noteworthy that both studies divided the course after onset into acute (first 3 days) and subacute (from 4th to 10th days) phases and focused more on the subacute phase. A previous study reported that patients with mild and moderate strokes exhibited different BP change patterns than patients with more severe strokes. 21 Therefore, the empirical partition of the acute and subacute phases may be reasonable for mild or moderate stroke patients; however, this approach remains questionable for individuals with more severe and unstable strokes. Consistent with the imbalanced autonomic activity during the antecedent 7 days after stroke onset, 22 we identified a synchronically dynamic and subsequent daily morning BP decline. Thus, the day-to-day BP variability indices in our study were derived based on these 7 daily morning BP measurements. Our findings suggested that day-to-day BP variability, particularly the SBP Max-Min, was independently associated with worse functional outcomes. Furthermore, this risk persisted over the long-term follow-up.
Another important finding of our study was that there was a significant difference in the daily morning BP in the first 3 days following the stroke onset between the patients with dichotomous outcomes at 12 months. This difference gradually diminished within the subsequent 4 days. The relationship between BP in acute stroke and worse outcomes has been consistently reported in most observational studies. [2] [3] [4] [5] However, several randomized controlled studies, such as the Scandinavian Candesartan acute stroke trial and China antihypertensive trial in acute ischemic stroke, 6 which were designed to investigate the rationale of BP lowering strategies in acute ischemic stroke, have failed to verify the clinical efficacy of these treatments. Our findings indicated that the mean SBP during the 24 hours following admission was associated with the baseline stroke severity; thus, we cannot exclude the possibility that a more severe stroke may result in a higher mean SBP. In this event, the baseline severity may be an indispensable confounder for the assessment of functional outcomes. Before further studies shed light on the pathophysiology of BP elevation, caution must be taken with regard to the initiation of antihypertensive treatments in acute ischemic stroke unless the patients are under consideration for thrombolysis therapy.
The influence of 24-hour BP variability in acute ischemic stroke remains controversial. In our study, no significant association was identified between the 24-hour BP variability and the functional outcomes at 12 months. Previous studies have reported that hour-to-hour BP variability or shortterm BP variability is associated with brain edema, diffusion weighted imaging lesion growth, a higher risk of intracranial hemorrhagic transformation and morbidity. 11, 23, 24 A recently published meta-analysis that pooled 18 studies suggested that SBP variability immediately after onset was associated with poor functional outcomes. 20 Nevertheless, the authors commented that the distinctive methodology of BP variability measurement in different studies should be taken into account in the interpretation and comparison of the results of various studies. Therefore, the current findings suggest that hour-to-hour BP variability may represent a more sensitive indicator for early outcomes, such as early neurological deterioration or infarct progression in the acute stage, rather than long-term functional outcomes. BP variability is a complex phenomenon that includes the short-term BP variability that occurs within 24 hours and the long-term BP variability that occurs over the day-to-day post-stroke period. Both factors share common physiological bases, such as sympathetic nervous system influences and baroreceptor reflexes; however, long-term BP variability has several unique underlying mediators, such as large artery stiffness and behavioral changes. 25 Daily morning SBP variability has been demonstrated to be an independent risk factor for all cause death and cardiovascular mortality in the general population in a long-term cohort study. 26 Moreover, long-term BP variability in post-stroke patients has been associated with cerebral microbleedings and deep white matter changes. 16 In the current study, the influence of daily morning BP variability was compared with 24-hour BP variability, and the findings suggested that daily morning BP variability in acute ischemic stroke conveyed more predictive information regarding the long-term functional outcomes.
Our study had several limitations. First, this investigation was a single center study; thus, the results should be interpreted cautiously with respect to generalizations. It is likely that daily morning SBP variability could predict long-term functional outcomes post-stroke; however, we cannot claim causality because of the observational nature of the study design. Second, the majority of the study population had a history of hypertension and antihypertensive drug treatment prior to the stroke. To the best of our knowledge, the effects of antihypertensive medications would be primarily reflected by the BP status. We did not consider the influence of antihypertensive medications or the class effects of antihypertensive drugs. However, only a small number of patients in our study took antihypertensive medications due to extremely high BP levels, which was underbalanced by comparison. Third, the long-term follow-up was conducted using a standardized questionnaire over the telephone and not face-to-face. Thus, it may be underpowered and uninformative to detect further underlying causes for worse functional outcomes, such as stroke recurrence, cognition decline, and coexisting cardiovascular diseases.
In summary, our study suggests that day-to-day BP variability during the 7 days post-stroke is associated with worse functional outcomes at 12 months. Thus, clinical practitioners should identify and provide more attention to patients who are at a high risk of disability during the 12 months post-stroke, even when patients are discharged with good functional outcomes. Further studies are warranted to better understand the underlying pathophysiological mechanism for this association. Abbreviations: ARV, average real variation; CI, confidence interval; CV, coefficient variation; DBP, diastolic blood pressure; OR, odds ratio; Q, quartiles; SBP, systolic blood pressure; Δ = maximum − minimum. Table 4 . Continued
